NCT05169177View on ClinicalTrials.gov

Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

October 17, 2022

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2026

Conditions
Liver Neoplasm
Trial Locations (5)

2145

NOT_YET_RECRUITING

Westmead Hospital, Westmead

2298

NOT_YET_RECRUITING

Calvary Mater Newcastle Hospital, Waratah

3000

NOT_YET_RECRUITING

Peter MacCallum Cancer Centre, Melbourne

NOT_YET_RECRUITING

The Austin Hospital, Melbourne

4102

RECRUITING

Princess Alexandra Hospital, Woolloongabba

Sponsors

Collaborators (1)

Austin Health
All Listed Sponsors
collaborator

Calvary Mater Newcastle, Australia

OTHER

collaborator

Western Sydney Local Health District

OTHER

collaborator

Austin Health

OTHER_GOV

collaborator

Peter MacCallum Cancer Centre, Australia

OTHER

collaborator

Princess Alexandra Hospital, Brisbane, Australia

OTHER

lead

University of Sydney

OTHER

NCT05169177 - Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy | Biotech Hunter | Biotech Hunter